Glaxo prevails in the Canadian Federal Court of Appeal

GlaxoSmithKline Canada has won its appeal against a 2008 judgment by the Tax Court of Canada that it paid a Swiss related party too much money for the active ingredient in Zantac.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: